Clinical Trials Browser

OTHER × Prostatic Neoplasms × orteronel × Clear all

NCT01816048 2019-12-09

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

Phase 2 Terminated

8 enrolled 15 charts

Prostatic Neoplasms

NCT01707966 2019-05-15

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Phase 3 Completed

Prostatic Neoplasms

NCT02053311 2018-07-30

Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents

Phase 3 Withdrawn

Prostatic Neoplasms

NCT01866423 2017-08-31

Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

4 enrolled 6 charts

Prostatic Neoplasms

NCT03211052 2017-07-07

NEPTUNE

Phase 2 Terminated

Prostatic Neoplasms

NCT02054793 2014-07-23

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms